← Leaderboards
Nathan B Fountain
University Of Virginia Charlottesville
$483,688
Attributed
$483,688
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$483,688 · 3
By mechanism
M01$373,258 · 2
K08$110,430 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Edward Perez-Reyes$8,746,219
- Edward H Bertram$5,624,705
- Colleen A McClung$22,656,392
- William B Levy$3,258,566
- Mark Quigg$250,340
Others in their field
Top investigators on “Partial Seizure”
- Daniel Lowenstein · Beth Israel Deaconess Medical Center$26,416,844
- Gregory A Worrell · Mayo Clinic Rochester$12,383,651
- Jerome None Engel · University Of California Los Angeles$11,648,104
- Laura M Hales · Extend Biosciences, Inc.$10,529,645
- Bin He · Mellon Pitts Corporation (Mpc Corp)$8,074,382
- Catherine A Schevon · Columbia University Health Sciences$7,614,061
Research focus
Partial SeizureBrain Disorder ChemotherapyClinical ResearchAnticonvulsantsDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationMiddle Childhood (6-11)Disease /Disorder OnsetPharmacokineticsExcitatory AminoacidGaba ReceptorHippocampusProtein StructureReceptor ExpressionInhibitor /AntagonistElectrodesInterneuronsLaboratory RatNeural DegenerationNmda ReceptorsAutoradiographyDisease /Disorder ModelIn Situ Hybridization
Grant awards (7)
TRIAL OF HARKOSERIDE FOR PARTIAL SEIZURES$48,533
M01 · FY2002 · RR
TRIAL OF HARKOSERIDE FOR PARTIAL SEIZURES$48,533
M01 · FY2001 · RR
NEW ANTICONVULSANT (UCB L059) IN CHILDREN$248,088
M01 · FY2000 · RR
INHIBITION IN ENTHORHINAL CORTEX IN CHRONIC EPILEPSY$110,430
K08 · FY2000 · NS
NEW ANTICONVULSANT (UCB L059) IN CHILDREN$28,104
M01 · FY2000 · RR
TRIAL OF HARKOSERIDE FOR PARTIAL SEIZURES$0
M01 · FY2000 · RR
TRIAL OF HARKOSERIDE FOR PARTIAL SEIZURES$0
M01 · FY2000 · RR